Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids
Arnheim, K.
MMW Fortschritte der Medizin 142(24): 18
2000
ISSN/ISBN: 1438-3276 PMID: 10895577 Document Number: 519221
Document emailed within 1 workday
Related Documents
Larosa, J.H.; Larosa, J.C. 2006: Coronary heart disease prevention in women: focus on lipids Minerva Cardioangiologica 54(3): 311-322Gotto, A.M.; Scott, L.; Manis, E. 1974: Prudent eating after 40. Relationship of diet to blood lipids and coronary heart disease Geriatrics 29(5): 109-114 Passim
Assmann, G. 1999: Secondary coronary heart disease prevention by red wine? Der Internist 40(9): 982
Wilhelmsen, L. 1982: Secondary prevention of coronary heart disease. A review Cor et Vasa 24(4): 216-227
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Kannel, W.B. 1974: The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study Giornale Italiano di Cardiologia 4(1): 123-137
Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
McKenna, C.J.; Sugrue, D.D. 1995: Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives Irish Medical Journal 88(6): 191
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
Enbergs, A.; Liese, A.; Heimbach, M.; Kerber, S.; Scheld, H.H.; Breithardt, G.; Kleine-Katthöfer, P.; Keil, U. 1997: Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region Zeitschrift für Kardiologie 86(4): 284-291
Pokrovskaia, E.V. 2004: Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES Kardiologiia 44(10): 82-83
Kawecka-Jaszczowa, K.; Szczeklik, J.; Mysik, M.; Miłkowski, A. 1976: Blood pressure values in men included in prevention of coronary heart disease Przeglad Lekarski 33(6): 623-628
Rattanapanone, V.; Jiviriyawat, Y. 1983: Serum lipids in normal subjects, coronary heart disease and cerebrovascular disease Journal of the Medical Association of Thailand 66(12): 779-784
Safwat, H.M.; Sharawy, M.; El Safouri, S. 1978: The effect of propranolol on the serum lipids in diabetics with coronary heart disease Journal of the Egyptian Medical Association 61(9-10): 577-583
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Lu, G.; Ouyang, S.; Pei, Z. 1999: Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease Hunan Yi Ke da Xue Xue Bao 24(1): 68-70
Novák, J. 1988: The program for primary prevention and secondary prevention of ischemic coronary disease and research at the Laboratory of Human Energy Resources of the University of Wyoming in Laramie Casopis Lekaru Ceskych 127(37-38): 1190-1192